Cstone Pharmaceuticals Stock Market Outlook
| CSPHF Stock | USD 0.70 0.02 2.78% |
Roughly 61% of CStone Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading CStone Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with CStone Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use CStone Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use CStone Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward CStone Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding CStone Pharmaceuticals is 'Strong Sell'. Macroaxis provides CStone Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CSPHF positions.
Execute CStone Pharmaceuticals Advice
The CStone recommendation should be used to complement the investment advice compiled from the current analysts' consensus on CStone Pharmaceuticals. Macroaxis does not own or have any residual interests in CStone Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CStone Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Small | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon CStone Pharmaceuticals has a Mean Deviation of 1.23, Standard Deviation of 4.01 and Variance of 16.06We provide trade advice to complement the prevailing expert consensus on CStone Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure CStone Pharmaceuticals is not overpriced, please confirm all CStone Pharmaceuticals fundamentals, including its ebitda and the relationship between the total debt and market capitalization . As CStone Pharmaceuticals appears to be a penny stock we also recommend to validate its shares owned by institutions numbers.
CStone Pharmaceuticals Trading Alerts and Improvement Suggestions
| CStone Pharmaceuticals generated a negative expected return over the last 90 days | |
| CStone Pharmaceuticals has some characteristics of a very speculative penny stock | |
| CStone Pharmaceuticals has high historical volatility and very poor performance | |
| The company reported the revenue of 243.72 M. Net Loss for the year was (1.92 B) with profit before overhead, payroll, taxes, and interest of 136.89 M. | |
| CStone Pharmaceuticals has accumulated about 1.36 B in cash with (1.48 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company shares are held by company insiders |
CStone Pharmaceuticals Returns Distribution Density
The distribution of CStone Pharmaceuticals' historical returns is an attempt to chart the uncertainty of CStone Pharmaceuticals' future price movements. The chart of the probability distribution of CStone Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use CStone Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CStone Pharmaceuticals returns is essential to provide solid investment analysis for CStone Pharmaceuticals.
| Mean Return | -0.28 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 4.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CStone Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CStone Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CStone Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CStone Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CStone pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | -0.42 | |
σ | Overall volatility | 4.20 | |
Ir | Information ratio | -0.09 |
CStone Pharmaceuticals Volatility Alert
CStone Pharmaceuticals exhibits very low volatility with skewness of -2.88 and kurtosis of 19.67. CStone Pharmaceuticals is a potential penny stock. Although CStone Pharmaceuticals may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in CStone Pharmaceuticals. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on CStone instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.CStone Pharmaceuticals Fundamentals Vs Peers
Comparing CStone Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CStone Pharmaceuticals' direct or indirect competition across all of the common fundamentals between CStone Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as CStone Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of CStone Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing CStone Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CStone Pharmaceuticals to competition |
| Fundamentals | CStone Pharmaceuticals | Peer Average |
| Return On Equity | -0.92 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Operating Margin | (3.42) % | (5.51) % |
| Current Valuation | 539.57 M | 16.62 B |
| Shares Outstanding | 1.19 B | 571.82 M |
| Shares Owned By Insiders | 47.83 % | 10.09 % |
| Shares Owned By Institutions | 17.63 % | 39.21 % |
| Price To Book | 4.33 X | 9.51 X |
| Price To Sales | 1.43 X | 11.42 X |
| Revenue | 243.72 M | 9.43 B |
| Gross Profit | 136.89 M | 27.38 B |
| EBITDA | (1.9 B) | 3.9 B |
| Net Income | (1.92 B) | 570.98 M |
| Cash And Equivalents | 1.36 B | 2.7 B |
| Cash Per Share | 1.15 X | 5.01 X |
| Total Debt | 115.81 M | 5.32 B |
| Debt To Equity | 0.25 % | 48.70 % |
| Current Ratio | 1.75 X | 2.16 X |
| Book Value Per Share | 0.80 X | 1.93 K |
| Cash Flow From Operations | (1.48 B) | 971.22 M |
| Earnings Per Share | (0.25) X | 3.12 X |
| Number Of Employees | 569 | 18.84 K |
| Beta | 0.0872 | -0.15 |
| Market Capitalization | 786.67 M | 19.03 B |
| Total Asset | 2.27 B | 29.47 B |
| Z Score | 3.6 | 8.72 |
| Net Asset | 2.27 B |
CStone Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CStone . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.7 | |||
| Day Typical Price | 0.7 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
About CStone Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell CStone Pharmaceuticals? Buying financial instruments such as CStone Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CStone Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hybrid Mix Funds Thematic Idea Now
Hybrid Mix Funds
Funds or Etfs that are made of portfolios of stocks, bonds, or cash instruments with different maturity horizons and characteristics. The Hybrid Mix Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hybrid Mix Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in CStone Pink Sheet
CStone Pharmaceuticals financial ratios help investors to determine whether CStone Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CStone with respect to the benefits of owning CStone Pharmaceuticals security.